13 May, 2026

Radiant Pharmaceuticals Handover 10 US-Manufactured Ventilators to Health Ministry

Share

DHAKA, Bangladesh – In a significant move to bolster the nation’s intensive care capabilities, Radiant Pharmaceuticals Limited officially handed over 10 state-of-the-art ICU ventilators of US origin to the Ministry of Health and Family Welfare.

The ceremony took place on Tuesday, May 12, 2026, where the life-saving equipment was presented to the Honorable Health Minister, Sardar Md Sakhawat Husain.

Leadership and Vision

This humanitarian initiative was driven by the leadership and strategic guidance of Musawath Shams Zahedee, Member of the Board of Directors of Radiant Pharmaceuticals Limited. Under his direction, the company has prioritized strengthening the country’s critical care infrastructure to ensure that advanced medical technology is accessible to those in need.

Strengthening National Healthcare

The donation comes at a crucial time for the healthcare sector. These advanced ventilators, manufactured in the USA, are designed to provide high-precision respiratory support for critically ill patients.

“Radiant Pharmaceuticals Limited remains steadfast in its commitment to advancing healthcare excellence,” stated a company representative during the event. “This contribution is a testament to our responsibility toward the nation and our dedication to supporting the government’s efforts in providing world-class healthcare services.”

A Commitment to Service

This handover is part of Radiant’s broader Corporate Social Responsibility (CSR) mission to serve the people of Bangladesh with care and integrity. By enhancing the capacity of government hospitals, Radiant aims to ensure that no patient is left without the critical support required during medical emergencies.

The Ministry of Health expressed deep appreciation for the gesture, noting that such public-private partnerships are vital for the continuous improvement of the country’s healthcare landscape.

Share
Table of Contents

DHAKA, Bangladesh – In a significant move to bolster the nation’s intensive care capabilities, Radiant Pharmaceuticals Limited officially handed over 10 state-of-the-art ICU ventilators of US origin to the Ministry of Health and Family Welfare.

The ceremony took place on Tuesday, May 12, 2026, where the life-saving equipment was presented to the Honorable Health Minister, Sardar Md Sakhawat Husain.

Leadership and Vision

This humanitarian initiative was driven by the leadership and strategic guidance of Musawath Shams Zahedee, Member of the Board of Directors of Radiant Pharmaceuticals Limited. Under his direction, the company has prioritized strengthening the country’s critical care infrastructure to ensure that advanced medical technology is accessible to those in need.

Strengthening National Healthcare

The donation comes at a crucial time for the healthcare sector. These advanced ventilators, manufactured in the USA, are designed to provide high-precision respiratory support for critically ill patients.

“Radiant Pharmaceuticals Limited remains steadfast in its commitment to advancing healthcare excellence,” stated a company representative during the event. “This contribution is a testament to our responsibility toward the nation and our dedication to supporting the government’s efforts in providing world-class healthcare services.”

A Commitment to Service

This handover is part of Radiant’s broader Corporate Social Responsibility (CSR) mission to serve the people of Bangladesh with care and integrity. By enhancing the capacity of government hospitals, Radiant aims to ensure that no patient is left without the critical support required during medical emergencies.

The Ministry of Health expressed deep appreciation for the gesture, noting that such public-private partnerships are vital for the continuous improvement of the country’s healthcare landscape.

Table of Contents

Confidentiality Note:

Any information related to the identities of the patient and reporter will be kept confidential unless it is subject to disclose due to regulatory obligation.

AcceptDecline